Innovate Biopharmaceuticals Announces Participation at the Ladenburg Thalmann 2018 Healthcare Conference

Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, today announced it intends to present at the Ladenburg Thalmann 2018 Healthcare Conference.  The conference is being held on October 2, 2018, at the Sofitel Hotel in New York City.

READ MORE

Read More
Neurotrope to Present at the Ladenburg Thalmann 2018 Healthcare Conference

Neurotrope, Inc. (NASDAQ: NTRP), announces that Dr. Charles Ryan, Neurotrope's Chief Executive Officer, will present a company overview at the Ladenburg Thalmann 2018 Healthcare Conference in New York on Tuesday, October 2nd, 2018.

A live webcast of the presentation will be on the "Events and Presentations" page in the "Investors and Media" section of the Company's website at http://www.neurotrope.com, available for replay for 90 days.

READ MORE

Read More